Jw Life Science Corp (234080) — Free Cash Flow Generation Index
Jw Life Science Corp (234080) has a Free Cash Flow Generation Index of 0.16x as of December 2025. Free cash flow of ₩809.90 Million represents 0% of operating cash flow (₩5.08 Billion). Read 234080 liabilities breakdown for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jw Life Science Corp Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Jw Life Science Corp across 11 annual periods. Explore 234080 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Jw Life Science Corp (2015–2025)
Year-by-year Free Cash Flow Generation Index for Jw Life Science Corp. For the full company profile including market capitalisation, see Jw Life Science Corp market cap and net worth.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | ₩27.10 Billion | ₩40.54 Billion | ₩13.43 Billion | ▼ -16.1% |
| 2024 | 0.80x | ₩40.38 Billion | ₩50.69 Billion | ₩10.31 Billion | ▲ +2.1% |
| 2023 | 0.78x | ₩29.31 Billion | ₩37.57 Billion | ₩8.27 Billion | ▲ +88.9% |
| 2022 | 0.41x | ₩5.84 Billion | ₩14.13 Billion | ₩8.29 Billion | ▲ +15.7% |
| 2021 | 0.36x | ₩10.77 Billion | ₩30.17 Billion | ₩18.98 Billion | ▼ -45.3% |
| 2020 | 0.65x | ₩30.52 Billion | ₩46.75 Billion | ₩15.93 Billion | ▼ -0.5% |
| 2019 | 0.66x | ₩15.92 Billion | ₩24.28 Billion | ₩8.09 Billion | ▼ -7.3% |
| 2018 | 0.71x | ₩25.57 Billion | ₩36.13 Billion | ₩10.04 Billion | ▲ +18.2% |
| 2017 | 0.60x | ₩13.20 Billion | ₩22.05 Billion | ₩8.77 Billion | ▼ -67.3% |
| 2016 | 1.83x | ₩29.45 Billion | ₩16.08 Billion | ₩13.37 Billion | ▼ -3.3% |
| 2015 | 1.89x | ₩49.03 Billion | ₩25.90 Billion | ₩23.14 Billion | — |